PMID- 11763311 OWN - NLM STAT- MEDLINE DCOM- 20020502 LR - 20191210 IS - 1052-9551 (Print) IS - 1052-9551 (Linking) VI - 10 IP - 4 DP - 2001 Dec TI - Use of novel t(11;14) and t(14;18) dual-fusion fluorescence in situ hybridization probes in the differential diagnosis of lymphomas of small lymphocytes. PG - 214-22 AB - Increasingly, molecular biologic techniques have become important in the diagnosis of non-Hodgkin lymphomas. In the differential diagnosis of lymphoma(s) of small lymphocytes (LSL), reliable detection of t(11;14) or t(14;18) would confirm the diagnosis of mantle cell lymphoma (MCL) or follicle center lymphoma (FCL), respectively. A total of 87 LSL cases (27 MCL, 39 FCL, 17 small lymphocytic lymphoma [SLL], 3 marginal zone lymphomas, and 1 paraimmunoblastic variant of SLL) were diagnosed by a combination of light microscopy, immunohistochemistry, and flow cytometric immunophenotyping. Interphase fluorescence in situ hybridization (FISH) for t(11;14) and t( 14;18) using dual-fusion probes (Vysis, Downers Grove, IL) was performed on touch (n = 69) or gravity (n = 18) preparations from these cases. Of 27 MCL cases tested, 25 (93%) had demonstrable t(11;14), none had t(14;18), and 2 were negative for t(11;14) and t(14;18). Twenty-five of 39 (64%) FCL cases had t(14;18), none had t(11;14), and the remaining FCL cases (14 cases [35%]) had neither t(11;14) nor t(14;18). All 17 (100%) SLL cases had neither t(11;14) nor t(14;18). All 3 (100%) marginal zone lymphoma cases had neither t(11;14) nor t(14;18). The case of paraimmunoblastic variant of SLL had t(11;14) and was negative for t(14;18). No discrepant [i.e., positive for both t(11;14) and t(14;18)] or false-positive cases were noted. Interphase FISH using these commercially available probes is a useful adjunct to light microscopy, immunohistochemistry, and flow cytometric immunophenotyping in the diagnosis of LSL. FISH can be performed successfully on archival single-cell preparations (touch preparations or gravity preparations) when fresh tissue is unavailable. No discordant or false-positive cases were identified. FAU - Frater, J L AU - Frater JL AD - Department of Clinical Pathology, Cleveland Clinic Foundation, Ohio 44195, USA. FAU - Tsiftsakis, E K AU - Tsiftsakis EK FAU - Hsi, E D AU - Hsi ED FAU - Pettay, J AU - Pettay J FAU - Tubbs, R R AU - Tubbs RR LA - eng PT - Evaluation Study PT - Journal Article PL - United States TA - Diagn Mol Pathol JT - Diagnostic molecular pathology : the American journal of surgical pathology, part B JID - 9204924 RN - 0 (DNA Probes) RN - 0 (DNA, Neoplasm) SB - IM MH - *Chromosomes, Human, Pair 11 MH - *Chromosomes, Human, Pair 14 MH - *Chromosomes, Human, Pair 18 MH - DNA Probes MH - DNA, Neoplasm/analysis MH - Diagnosis, Differential MH - Flow Cytometry MH - Humans MH - *In Situ Hybridization, Fluorescence MH - Leukemia, Lymphocytic, Chronic, B-Cell/classification/*genetics/pathology MH - Reproducibility of Results MH - Retrospective Studies MH - *Translocation, Genetic EDAT- 2002/01/05 10:00 MHDA- 2002/05/03 10:01 CRDT- 2002/01/05 10:00 PHST- 2002/01/05 10:00 [pubmed] PHST- 2002/05/03 10:01 [medline] PHST- 2002/01/05 10:00 [entrez] AID - 10.1097/00019606-200112000-00002 [doi] PST - ppublish SO - Diagn Mol Pathol. 2001 Dec;10(4):214-22. doi: 10.1097/00019606-200112000-00002.